TABLE 5.
1998 CDC recommended regimens for uncomplicated vulvovaginal candidiasisa
| Intravaginal agents |
| Butoconazole 2% cream 5 g intravaginally for 3 daysbc |
| or |
| Clotrimazole 1% cream 5 g intravaginally for 7–14 daysbc |
| or |
| Clotrimazole 100-mg vaginal tablet for 7 daysb |
| or |
| Clotrimazole 500-mg vaginal tablet, one tablet in a single applicationb |
| or |
| Miconzole 2% cream 5 g intravaginally for 7 daysbc |
| or |
| Miconazole 200 mg vaginal suppository, one suppository daily for 3 daysbc |
| or |
| Miconazole 100 mg vaginal suppository, one suppository daily for 7 daysbc |
| or |
| Nystatin 1000,000-unit vaginal tablet, one tablet daily for 14 days |
| or |
| Tioconazole 6.5% ointment 5 g intravaginally in a single applicationbc |
| or |
| Terconazole 0.4% cream 5 g intravaginally for 7 days,b |
| or |
| Terconazole 0.8% cream 5 g intravaginally for 3 days,b |
| or |
| Terconazole 80 mg vaginal suppository, one suppository daily for 3 daysb |
| Oral agent |
| Fluconazole 150 mg oral tablet, one tablet in single dose |
Adapted from reference 36.
These creams and suppositories are oil based and might weaken latex condoms and diaphragms. Refer to condom product labeling for additional information.
Over-the-counter preparation.